Signe Fransen

1.6k total citations
25 papers, 1.1k citations indexed

About

Signe Fransen is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Signe Fransen has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Virology, 19 papers in Infectious Diseases and 9 papers in Molecular Biology. Recurrent topics in Signe Fransen's work include HIV Research and Treatment (22 papers), HIV/AIDS drug development and treatment (19 papers) and Biochemical and Molecular Research (6 papers). Signe Fransen is often cited by papers focused on HIV Research and Treatment (22 papers), HIV/AIDS drug development and treatment (19 papers) and Biochemical and Molecular Research (6 papers). Signe Fransen collaborates with scholars based in United States, Canada and Spain. Signe Fransen's co-authors include Christos J. Petropoulos, Wei Huang, Jonathan Toma, Jeannette M. Whitcomb, Ellen E. Paxinos, Soumi Gupta, Eric Stawiski, Terri Wrin, Colombe Chappey and Kay Limoli and has published in prestigious journals such as Cancer Research, Clinical Infectious Diseases and Journal of Virology.

In The Last Decade

Signe Fransen

25 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Signe Fransen United States	15	997	876	277	163	144	25	1.1k
Kay Limoli United States	12	1.1k 1.1×	1.1k 1.2×	165 0.6×	152 0.9×	111 0.8×	14	1.2k
Roberta D’Arrigo Italy	20	735 0.7×	717 0.8×	261 0.9×	160 1.0×	75 0.5×	37	957
Jonathan Toma United States	13	778 0.8×	566 0.6×	175 0.6×	149 0.9×	228 1.6×	21	865
Luke C. Swenson Canada	17	690 0.7×	585 0.7×	172 0.6×	144 0.9×	84 0.6×	35	834
Anni Winckelmann Denmark	12	718 0.7×	544 0.6×	198 0.7×	154 0.9×	310 2.2×	20	938
Elly Baan Netherlands	15	768 0.8×	533 0.6×	115 0.4×	142 0.9×	239 1.7×	21	859
Mary O’Hearn United States	6	599 0.6×	676 0.8×	106 0.4×	136 0.8×	115 0.8×	9	838
Tonie Cilliers United States	14	780 0.8×	508 0.6×	208 0.8×	91 0.6×	285 2.0×	19	854
Katherine M. Bruner United States	7	1.2k 1.2×	807 0.9×	181 0.7×	264 1.6×	437 3.0×	7	1.3k
Mary Soliman United States	5	525 0.5×	374 0.4×	102 0.4×	156 1.0×	202 1.4×	8	659

Countries citing papers authored by Signe Fransen

Since Specialization

Citations

This map shows the geographic impact of Signe Fransen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Signe Fransen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Signe Fransen more than expected).

Fields of papers citing papers by Signe Fransen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Signe Fransen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Signe Fransen. The network helps show where Signe Fransen may publish in the future.

Co-authorship network of co-authors of Signe Fransen

This figure shows the co-authorship network connecting the top 25 collaborators of Signe Fransen. A scholar is included among the top collaborators of Signe Fransen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Signe Fransen. Signe Fransen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carroll, Lauren, et al.. (2023). Differential impact of test performance characteristics on burden-to-benefit tradeoffs for blood-based colorectal cancer screening: A microsimulation analysis. Journal of Medical Screening. 30(4). 175–183. 3 indexed citations

Putcha, Girish, et al.. (2022). Abstract 2240: Interception versus prevention in cancer screening: Results from the CRC-MAPS model. Cancer Research. 82(12_Supplement). 2240–2240. 1 indexed citations

Fransen, Signe, Chuanbo Xu, Jeffrey P. Gregg, et al.. (2021). S346 Enrollment Rate of African Americans in a Colon Cancer Screening Trial at a Historically Black College and University Is Similar to Other Patient Populations. The American Journal of Gastroenterology. 116(1). S149–S150. 1 indexed citations

Napolitano, Laura A., Agnès Paquet, Neil Parkin, et al.. (2013). Minimal sequence variability of the region of HIV-1 integrase targeted by the Abbott RealTime HIV-1 viral load assay in clinical specimens with reduced susceptibility to raltegravir. Journal of Virological Methods. 193(2). 693–696. 2 indexed citations

Huang, Wei, et al.. (2013). Multiple Genetic Pathways Involving Amino Acid Position 143 of HIV-1 Integrase Are Preferentially Associated with Specific Secondary Amino Acid Substitutions and Confer Resistance to Raltegravir and Cross-Resistance to Elvitegravir. Antimicrobial Agents and Chemotherapy. 57(9). 4105–4113. 26 indexed citations

Fransen, Signe, et al.. (2012). Substitutions at Amino Acid Positions 143, 148, and 155 of HIV-1 Integrase Define Distinct Genetic Barriers to Raltegravir Resistance In Vivo. Journal of Virology. 86(13). 7249–7255. 31 indexed citations

Cloherty, Gavin, Signe Fransen, Laura A. Napolitano, et al.. (2011). Performance of the Abbott RealTime HIV-1 Viral Load Assay Is Not Impacted by Integrase Inhibitor Resistance-Associated Mutations. Journal of Clinical Microbiology. 49(4). 1631–1634. 3 indexed citations

Hatano, Hiroyu, Harry Lampiris, Signe Fransen, et al.. (2010). Evolution of Integrase Resistance During Failure of Integrase Inhibitor-Based Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 54(4). 389–393. 62 indexed citations

Huang, Wei, Jonathan Toma, Signe Fransen, et al.. (2010). Mutational pathways and genetic barriers to CXCR4-mediated entry by human immunodeficiency virus type 1. Virology. 409(2). 308–318. 6 indexed citations

10.

Gupta, Soumi, Signe Fransen, Ellen E. Paxinos, et al.. (2010). Combinations of Mutations in the Connection Domain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Assessing the Impact on Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitor Resistance. Antimicrobial Agents and Chemotherapy. 54(5). 1973–1980. 43 indexed citations

11.

Huang, Wei, Jonathan Toma, Eric Stawiski, et al.. (2009). Characterization of Human Immunodeficiency Virus Type 1 Populations Containing CXCR4-Using Variants from Recently Infected Individuals. AIDS Research and Human Retroviruses. 25(8). 795–802. 31 indexed citations

12.

Fransen, Signe, Marina Karmochkine, Wei Huang, et al.. (2009). Longitudinal Analysis of Raltegravir Susceptibility and Integrase Replication Capacity of Human Immunodeficiency Virus Type 1 during Virologic Failure. Antimicrobial Agents and Chemotherapy. 53(10). 4522–4524. 41 indexed citations

13.

Fransen, Signe. (2008). Performance Characteristics and Validation of the PhenoSense HIV Integrase Assay. 46th Annual Meeting. 4 indexed citations

14.

Huang, Wei, Jonathan Toma, Signe Fransen, et al.. (2008). Coreceptor Tropism Can Be Influenced by Amino Acid Substitutions in the gp41 Transmembrane Subunit of Human Immunodeficiency Virus Type 1 Envelope Protein. Journal of Virology. 82(11). 5584–5593. 74 indexed citations

15.

Huang, Wei, Susan H. Eshleman, Jonathan Toma, et al.. (2007). Coreceptor Tropism in Human Immunodeficiency Virus Type 1 Subtype D: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations. Journal of Virology. 81(15). 7885–7893. 130 indexed citations

16.

Schols, Dominique, Kurt Vermeire, Signe Fransen, et al.. (2005). Multi-drug resistant HIV-1 is sensitive to inhibition by chemokine receptor antagonists. 250. 3 indexed citations

17.

Fransen, Signe, et al.. (2000). RANTES Production by T Cells and CD8‐Mediated Inhibition of Human Immunodeficiency Virus Gene Expression before Initiation of Potent Antiretroviral Therapy Predict Sustained Suppression of Viral Replication. The Journal of Infectious Diseases. 181(2). 505–512. 16 indexed citations

18.

Conway, Brian, Valentina Montessori, Danielle Rouleau, et al.. (1999). Primary Lamivudine Resistance in Acute/Early Human Immunodeficiency Virus Infection. Clinical Infectious Diseases. 28(4). 910–911. 12 indexed citations

19.

Harris, Marianne, et al.. (1998). A Pilot Study of Nevirapine, Indinavir, and Lamivudine among Patients with Advanced Human Immunodeficiency Virus Disease Who Have Had Failure of Combination Nucleoside Therapy. The Journal of Infectious Diseases. 177(6). 1514–1520. 58 indexed citations

20.

Rouleau, Danielle, Brian Conway, Janet Raboud, et al.. (1997). Stavudine plus Lamivudine in Advanced Human Immunodeficiency Virus Disease: A Short‐Term Pilot Study. The Journal of Infectious Diseases. 176(5). 1156–1160. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact